[ad_1]
More than 5,000 volunteers registered this Tuesday on the website where the registration for the national covid-19 serovial panel takes place, with almost 45% of the samples filled on the first day of operation.
In a statement, the Institute of Molecular Medicine (IMM) states that, despite all the technical problems registered on the platform, 5,355 volunteers were registered as of 9:00 p.m. on Tuesday, almost 45% of the total expected sample. meet in a month.
The IMM points out that the launch of the national Covid-19 serological panel was welcomed with “the greatest interest and adherence of the Portuguese,” with “the high influx” to the platform exceeded “in all estimates” and that they were “far above from the historical references of similar studies “.
For this reason, we are working to resolve the technical issues necessary to ensure a correct and efficient registration of volunteers ”, says the IMM, estimating that the situation will normalize in the coming days.
Subscriptions to site started at 00:00 on Tuesday, but the platform has been experiencing technical problems due to high participation.
To participate in the national serological panel, registrations must be made exclusively through the platform. According to the IMM, helplines should be consulted only for study-related questions.
STUDY DETAILS
The analysis is simple: it is only necessary to collect the blood at one of the 314 collection points of the Germano de Sousa Laboratory Medicine Center, spread over 102 municipalities in mainland Portugal and islands.
The research will be based on a sample with proportional stratification of the Portuguese population by age group – under 18, between 18 and 54 years old and 55 years or more – and population density of the regions – low, medium and high. The characterization of the sample had the contribution of specialists from Pordata and the Faculty of Medicine of the University of Lisbon.
The study was funded with two million euros by the Francisco Manuel dos Santos Society (SFMS) and the Jerónimo Martins Group (JM).
